CRWM
ABBV icon

Castle Rock Wealth Management’s AbbVie ABBV Stock Holding History

Castle Rock Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,200
Closed -$1K – 159
2019
Q2 		$1K Buy
+1,200
New +$94.3K ﹤0.01% 145

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Castle Rock Wealth Management's ABBV Position: Q2 2026 in Review

Castle Rock Wealth Management increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $3.66K and bringing the position to 1,515 shares worth $380K. The position accounts for 0.07% of the portfolio, ranked #196.

Castle Rock Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 25 quarters since. The position peaked at $1.38M in Q4 2024. 2,088 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Castle Rock Wealth Management held 1,515 shares of AbbVie worth $380K as of Q2 2026.
  • Castle Rock Wealth Management bought 17 AbbVie shares in Q2 2026, an estimated $3.66K.
  • AbbVie made up 0.07% of Castle Rock Wealth Management's portfolio in Q2 2026, its #196 holding.
  • Castle Rock Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 25 quarters since.
  • Castle Rock Wealth Management's AbbVie position peaked at $1.38M in Q4 2024.
  • 2,088 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Castle Rock Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.